Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

NCT04419519

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)

NCT04191304

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Ann Arbor, Michigan, United States
View all 52 locations
View Trial Details
Active, not recruiting

A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia

NCT06637501

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Cleveland Clinic Florida Weston, Florida, United States
  • Northwest Georgia Oncology Centers Marietta Marietta, Georgia, United States
  • Illinois Cancer Specialists (Niles) Usor Niles, Illinois, United States
  • The University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
View all 32 locations
View Trial Details
Active, not recruiting

A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML

NCT03591510

Conditions
FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Pavia, PV, Italy
View all 15 locations
View Trial Details
Active, not recruiting

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

NCT06413498

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital Gilbert, Arizona, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 117 locations
View Trial Details

Related conditions